Literature DB >> 20080402

Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene.

Haiyan Zhou1, Suzanne Lillis, Ryan E Loy, Farshid Ghassemi, Michael R Rose, Fiona Norwood, Kerry Mills, Safa Al-Sarraj, Russell J M Lane, Lucy Feng, Emma Matthews, Caroline A Sewry, Stephen Abbs, Stefan Buk, Michael Hanna, Susan Treves, Robert T Dirksen, Gerhard Meissner, Francesco Muntoni, Heinz Jungbluth.   

Abstract

The skeletal muscle ryanodine receptor plays a crucial role in excitation-contraction (EC) coupling and is implicated in various congenital myopathies. The periodic paralyses are a heterogeneous, dominantly inherited group of conditions mainly associated with mutations in the SCN4A and the CACNA1S genes. The interaction between RyR1 and DHPR proteins underlies depolarization-induced Ca(2+) release during EC coupling in skeletal muscle. We report a 35-year-old woman presenting with signs and symptoms of a congenital myopathy at birth and repeated episodes of generalized, atypical normokalaemic paralysis in her late teens. Genetic studies of this patient revealed three heterozygous RYR1 substitutions (p.Arg2241X, p.Asp708Asn and p.Arg2939Lys) associated with marked reduction of the RyR1 protein and abnormal DHPR distribution. We conclude that RYR1 mutations may give rise to both myopathies and atypical periodic paralysis, and RYR1 mutations may underlie other unresolved cases of periodic paralysis with unusual features. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080402      PMCID: PMC3136116          DOI: 10.1016/j.nmd.2009.12.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  30 in total

1.  Central core disease is due to RYR1 mutations in more than 90% of patients.

Authors:  Shiwen Wu; M Carlos A Ibarra; May Christine V Malicdan; Kumiko Murayama; Yasuko Ichihara; Hirosato Kikuchi; Ikuya Nonaka; Satoru Noguchi; Yukiko K Hayashi; Ichizo Nishino
Journal:  Brain       Date:  2006-04-18       Impact factor: 13.501

2.  Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores.

Authors:  Nicole Monnier; Isabelle Marty; Julien Faure; Claudia Castiglioni; Claude Desnuelle; Sabrina Sacconi; Brigitte Estournet; Ana Ferreiro; Norma Romero; Annie Laquerriere; Leila Lazaro; Jean-Jacques Martin; Eva Morava; Annick Rossi; Anneke Van der Kooi; Marianne de Visser; Corien Verschuuren; Joël Lunardi
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

3.  150th ENMC International Workshop: Core Myopathies, 9-11th March 2007, Naarden, The Netherlands.

Authors:  Heinz Jungbluth; Francesco Muntoni; Ana Ferreiro
Journal:  Neuromuscul Disord       Date:  2008-10-22       Impact factor: 4.296

4.  Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.

Authors:  Heinz Jungbluth; Haiyan Zhou; Caroline A Sewry; Stephanie Robb; Susan Treves; Marc Bitoun; Pascale Guicheney; Anna Buj-Bello; Carsten Bönnemann; Francesco Muntoni
Journal:  Neuromuscul Disord       Date:  2007-03-21       Impact factor: 4.296

5.  Two central core disease (CCD) deletions in the C-terminal region of RYR1 alter muscle excitation-contraction (EC) coupling by distinct mechanisms.

Authors:  Alla D Lyfenko; Sylvie Ducreux; Ying Wang; Le Xu; Francesco Zorzato; Ana Ferreiro; Gerhard Meissner; Susan Treves; Robert T Dirksen
Journal:  Hum Mutat       Date:  2007-01       Impact factor: 4.878

6.  Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies.

Authors:  Haiyan Zhou; Heinz Jungbluth; Caroline A Sewry; Lucy Feng; Enrico Bertini; Kate Bushby; Volker Straub; Helen Roper; Michael R Rose; Martin Brockington; Maria Kinali; Adnan Manzur; Stephanie Robb; Richard Appleton; Sonia Messina; Adele D'Amico; Ros Quinlivan; Michael Swash; Clemens R Müller; Susan Brown; Susan Treves; Francesco Muntoni
Journal:  Brain       Date:  2007-05-04       Impact factor: 13.501

7.  Zebrafish relatively relaxed mutants have a ryanodine receptor defect, show slow swimming and provide a model of multi-minicore disease.

Authors:  Hiromi Hirata; Takaki Watanabe; Jun Hatakeyama; Shawn M Sprague; Louis Saint-Amant; Ayako Nagashima; Wilson W Cui; Weibin Zhou; John Y Kuwada
Journal:  Development       Date:  2007-06-27       Impact factor: 6.868

8.  Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies.

Authors:  Ana Ferreiro; Susana Quijano-Roy; Claire Pichereau; Behzad Moghadaszadeh; Nathalie Goemans; Carsten Bönnemann; Heinz Jungbluth; Volker Straub; Marcello Villanova; Jean-Paul Leroy; Norma B Romero; Jean-Jacques Martin; Francesco Muntoni; Thomas Voit; Brigitte Estournet; Pascale Richard; Michel Fardeau; Pascale Guicheney
Journal:  Am J Hum Genet       Date:  2002-08-21       Impact factor: 11.025

9.  Characterization of recessive RYR1 mutations in core myopathies.

Authors:  Haiyan Zhou; Naohiro Yamaguchi; Le Xu; Ying Wang; Caroline Sewry; Heinz Jungbluth; Francesco Zorzato; Enrico Bertini; Francesco Muntoni; Gerhard Meissner; Susan Treves
Journal:  Hum Mol Genet       Date:  2006-08-29       Impact factor: 6.150

10.  Mutations in the RYR1 gene in Italian patients at risk for malignant hyperthermia: evidence for a cluster of novel mutations in the C-terminal region.

Authors:  L Galli; A Orrico; S Cozzolino; V Pietrini; V Tegazzin; V Sorrentino
Journal:  Cell Calcium       Date:  2002-09       Impact factor: 6.817

View more
  32 in total

1.  Phosphoinositide substrates of myotubularin affect voltage-activated Ca²⁺ release in skeletal muscle.

Authors:  Estela González Rodríguez; Romain Lefebvre; Dóra Bodnár; Claude Legrand; Peter Szentesi; János Vincze; Karine Poulard; Justine Bertrand-Michel; Laszlo Csernoch; Anna Buj-Bello; Vincent Jacquemond
Journal:  Pflugers Arch       Date:  2014-05       Impact factor: 3.657

2.  Clinical utility gene card for: malignant hyperthermia.

Authors:  Henry Rosenberg; Henrik Rueffert
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

Review 3.  Ryanodine receptors: structure and function.

Authors:  Filip Van Petegem
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

Review 4.  Phosphoinositides in Ca(2+) signaling and excitation-contraction coupling in skeletal muscle: an old player and newcomers.

Authors:  Laszlo Csernoch; Vincent Jacquemond
Journal:  J Muscle Res Cell Motil       Date:  2015-09-16       Impact factor: 2.698

5.  Defects in Ca2+ release associated with local expression of pathological ryanodine receptors in mouse muscle fibres.

Authors:  Romain Lefebvre; Claude Legrand; Estela González-Rodríguez; Linda Groom; Robert T Dirksen; Vincent Jacquemond
Journal:  J Physiol       Date:  2011-10-03       Impact factor: 5.182

Review 6.  Physiology and pathophysiology of excitation-contraction coupling: the functional role of ryanodine receptor.

Authors:  Gaetano Santulli; Daniel R Lewis; Andrew R Marks
Journal:  J Muscle Res Cell Motil       Date:  2017-06-26       Impact factor: 2.698

Review 7.  Ryanodine receptors: structure, expression, molecular details, and function in calcium release.

Authors:  Johanna T Lanner; Dimitra K Georgiou; Aditya D Joshi; Susan L Hamilton
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-10-20       Impact factor: 10.005

Review 8.  Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.

Authors:  Sheila Riazi; Natalia Kraeva; Philip M Hopkins
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

9.  Using exome data to identify malignant hyperthermia susceptibility mutations.

Authors:  Stephen G Gonsalves; David Ng; Jennifer J Johnston; Jamie K Teer; Peter D Stenson; David N Cooper; James C Mullikin; Leslie G Biesecker
Journal:  Anesthesiology       Date:  2013-11       Impact factor: 7.892

Review 10.  Triadopathies: an emerging class of skeletal muscle diseases.

Authors:  James J Dowling; Michael W Lawlor; Robert T Dirksen
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.